According to HTG Molecular Diagnostics 's latest financial reports the company's current revenue (TTM) is $6.21 M. In 2022 the company made a revenue of $6.36 M a decrease over the years 2021 revenue that were of $8.9 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $6.21 M | -2.39% |
2022 | $6.36 M | -28.52% |
2021 | $8.9 M | 4.19% |
2020 | $8.54 M | -55.48% |
2019 | $19.2 M | -10.7% |
2018 | $21.5 M | 45.69% |
2017 | $14.75 M | 187.56% |
2016 | $5.13 M | 27% |
2015 | $4.04 M | 21.41% |
2014 | $3.32 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Lexicon Pharmaceuticals
LXRX | $1.2 M | -80.61% | ๐บ๐ธ USA |
Affimed
AFMD | $8.95 M | 44.15% | ๐ฉ๐ช Germany |
Calithera Biosciences
CALA | N/A | N/A | ๐บ๐ธ USA |